國立高雄大學圖資館 |

登入

回首頁

Clinical management of acute lymphoblastic leukemiafrom bench to bedside /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Clinical management of acute lymphoblastic leukemiaedited by Mark R. Litzow, Elizabeth A. Raetz.
其他題名:	from bench to bedside /
其他作者:	Litzow, Mark R.
出版者:	Cham :Springer International Publishing :2022.
面頁冊數:	xi, 437 p. :ill., digital ;24 cm.
Contained By:	Springer Nature eBook
標題:	Lymphoblastic leukemia.
電子資源:	https://doi.org/10.1007/978-3-030-85147-7
ISBN:	9783030851477$q(electronic bk.)

Clinical management of acute lymphoblastic leukemiafrom bench to bedside /
Clinical management of acute lymphoblastic leukemiafrom bench to bedside /[electronic resource] :edited by Mark R. Litzow, Elizabeth A. Raetz. - Cham :Springer International Publishing :2022. - xi, 437 p. :ill., digital ;24 cm.

TRANSLATIONAL SCIENCE -- Molecular pathways and targets in B cell progenitor acute lymphoblastic leukemia -- Genetic Mechanisms in T-Cell Acute Lymphoblastic Leukemia -- Minimal Residual Disease in Acute Lymphoblastic Leukemia - Techniques and Application -- THERAPEUTICS -- Treatment of Pediatric B and T cell ALL -- Treatment of Adult B and T cell Acute Lymphoblastic Leukemia: An Overview of Current Treatments and Novel Advances -- Acute Lymphoblastic Leukemia in Infants: A distinctive, high risk subtype of childhood ALL -- Treatment of Elderly Patients with Acute Lymphoblastic Leukemia -- Treatment of Childhood Philadelphia-Chromosome Positive Acute Lymphoblastic Leukemia -- Treatment of adult Philadelphia chromosome positive ALL -- Treatment of Ph-like ALL -- Prophylaxis and treatment of central nervous system (CNS) ALL -- Late effects of therapy of acute lymphoblastic leukemia -- NEW AND EXISTING MODALITIES OF THERAPY -- Monoclonal Antibody Based Treatment and Other New Agents for B-Lineage ALL -- New Agents for the Treatment of T-Cell ALL -- The development and management of treatment with chimeric-antigen receptor T cell (CAR-T) -- Hematopoietic Stem Cell Transplantation in Adults with Acute Lymphoblastic Leukemia (ALL) -- Hematopoietic Stem Cell Transplantation in Pediatric Acute Lymphoblastic Leukemia.

This book provides a state-of-the-art overview of acute lymphoblastic leukemia (ALL) The first section of the book presents the translational science behind ALL, reviewing molecular pathways and targets in B- and T-cell ALL, as well as techniques and application of minimal residual disease testing. The second section spotlights ALL management strategies for patients across the spectrum, from infants to the elderly. The final section outlines current and new advances in ALL treatment, including new monoclonal antibodies and allogenic and autologous HSCT. Written by experts in the field, Clinical Management of Acute Lymphoblastic Leukemia: From Bench to Bedside is a valuable resource that will guide patient management, stimulate investigative efforts, and increase understanding of the biologic underpinnings of the disease.

ISBN: 9783030851477$q(electronic bk.)

Standard No.: 10.1007/978-3-030-85147-7doiSubjects--Topical Terms:

920024
Lymphoblastic leukemia.

LC Class. No.: RC280.L9 / C55 2022

Dewey Class. No.: 616.99419

Clinical management of acute lymphoblastic leukemiafrom bench to bedside /
LDR:03178nmm a2200325 a 4500 001 619639
003 DE-He213
005 20211216174737.0
006 m d
007 cr nn 008maaau
008 221103s2022 sz s 0 eng d
020 $a 9783030851477$q(electronic bk.)
020 $a 9783030851460$q(paper)
024 7 $a 10.1007/978-3-030-85147-7 $2 doi
035 $a 978-3-030-85147-7
040 $a GP $c GP
041 0 $a eng
050 4 $a RC280.L9 $b C55 2022
072 7 $a MJF $2 bicssc
072 7 $a MED038000 $2 bisacsh
072 7 $a MJF $2 thema
082 0 4 $a 616.99419 $2 23
090 $a RC280.L9 $b C641 2022
245 0 0 $a Clinical management of acute lymphoblastic leukemia $h [electronic resource] : $b from bench to bedside / $c edited by Mark R. Litzow, Elizabeth A. Raetz.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2022.
300 $a xi, 437 p. : $b ill., digital ; $c 24 cm.
505 0 $a TRANSLATIONAL SCIENCE -- Molecular pathways and targets in B cell progenitor acute lymphoblastic leukemia -- Genetic Mechanisms in T-Cell Acute Lymphoblastic Leukemia -- Minimal Residual Disease in Acute Lymphoblastic Leukemia - Techniques and Application -- THERAPEUTICS -- Treatment of Pediatric B and T cell ALL -- Treatment of Adult B and T cell Acute Lymphoblastic Leukemia: An Overview of Current Treatments and Novel Advances -- Acute Lymphoblastic Leukemia in Infants: A distinctive, high risk subtype of childhood ALL -- Treatment of Elderly Patients with Acute Lymphoblastic Leukemia -- Treatment of Childhood Philadelphia-Chromosome Positive Acute Lymphoblastic Leukemia -- Treatment of adult Philadelphia chromosome positive ALL -- Treatment of Ph-like ALL -- Prophylaxis and treatment of central nervous system (CNS) ALL -- Late effects of therapy of acute lymphoblastic leukemia -- NEW AND EXISTING MODALITIES OF THERAPY -- Monoclonal Antibody Based Treatment and Other New Agents for B-Lineage ALL -- New Agents for the Treatment of T-Cell ALL -- The development and management of treatment with chimeric-antigen receptor T cell (CAR-T) -- Hematopoietic Stem Cell Transplantation in Adults with Acute Lymphoblastic Leukemia (ALL) -- Hematopoietic Stem Cell Transplantation in Pediatric Acute Lymphoblastic Leukemia.
520 $a This book provides a state-of-the-art overview of acute lymphoblastic leukemia (ALL) The first section of the book presents the translational science behind ALL, reviewing molecular pathways and targets in B- and T-cell ALL, as well as techniques and application of minimal residual disease testing. The second section spotlights ALL management strategies for patients across the spectrum, from infants to the elderly. The final section outlines current and new advances in ALL treatment, including new monoclonal antibodies and allogenic and autologous HSCT. Written by experts in the field, Clinical Management of Acute Lymphoblastic Leukemia: From Bench to Bedside is a valuable resource that will guide patient management, stimulate investigative efforts, and increase understanding of the biologic underpinnings of the disease.
650 0 $a Lymphoblastic leukemia. $3 920024
650 0 $a Lymphoblastic leukemia $x Treatment. $3 920025
650 1 4 $a Hematology. $3 274899
650 2 4 $a Oncology. $3 195181
700 1 $a Litzow, Mark R. $3 920022
700 1 $a Raetz, Elizabeth A. $3 920023
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-3-030-85147-7
950 $a Medicine (SpringerNature-11650)